EP1311276A4 - Methods of preventing or treating diseases and conditions using complex carbohydrates - Google Patents

Methods of preventing or treating diseases and conditions using complex carbohydrates

Info

Publication number
EP1311276A4
EP1311276A4 EP01959852A EP01959852A EP1311276A4 EP 1311276 A4 EP1311276 A4 EP 1311276A4 EP 01959852 A EP01959852 A EP 01959852A EP 01959852 A EP01959852 A EP 01959852A EP 1311276 A4 EP1311276 A4 EP 1311276A4
Authority
EP
European Patent Office
Prior art keywords
preventing
conditions
methods
treating diseases
complex carbohydrates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01959852A
Other languages
German (de)
French (fr)
Other versions
EP1311276A1 (en
Inventor
Harold G Brown
Karen K Brown
Carol A Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermal Research Laboratories Inc
Original Assignee
Dermal Research Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermal Research Laboratories Inc filed Critical Dermal Research Laboratories Inc
Publication of EP1311276A1 publication Critical patent/EP1311276A1/en
Publication of EP1311276A4 publication Critical patent/EP1311276A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP01959852A 2000-07-31 2001-07-31 Methods of preventing or treating diseases and conditions using complex carbohydrates Withdrawn EP1311276A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22204600P 2000-07-31 2000-07-31
US222046P 2000-07-31
PCT/US2001/041473 WO2002009728A1 (en) 2000-07-31 2001-07-31 Methods of preventing or treating diseases and conditions using complex carbohydrates

Publications (2)

Publication Number Publication Date
EP1311276A1 EP1311276A1 (en) 2003-05-21
EP1311276A4 true EP1311276A4 (en) 2007-09-12

Family

ID=22830558

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01959852A Withdrawn EP1311276A4 (en) 2000-07-31 2001-07-31 Methods of preventing or treating diseases and conditions using complex carbohydrates

Country Status (5)

Country Link
EP (1) EP1311276A4 (en)
AU (2) AU8136801A (en)
CA (1) CA2417867C (en)
NZ (2) NZ524076A (en)
WO (1) WO2002009728A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916565A (en) 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
WO2002060471A2 (en) * 2001-01-30 2002-08-08 Ich Productions Limited Ligands for receptor-like protein tyrosine phosphatases
ITMI20021866A1 (en) * 2002-08-30 2004-02-29 Luigi Allegra PHARMACEUTICAL PREPARATION IN COLLOIDAL FORM USEFUL IN THE TREATMENT OF SKIN DISEASES.
US7060691B2 (en) * 2002-10-10 2006-06-13 Giuseppe Petrigni Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
US20040161476A1 (en) * 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
US7511026B2 (en) 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
US20070225484A1 (en) * 2006-03-25 2007-09-27 Framroze Bomi P Process for the Isolation and Stabilization of Low-Molecular Weight Aminoglycans from Waste Egg Shells
MX2008014403A (en) * 2006-05-11 2009-03-23 Sandra Gobbo Hyaluronic acid binary mixtures and therapeutic use thereof.
ITMI20061030A1 (en) 2006-05-26 2007-11-27 Altergon Sa NEW COMPOSITION INCLUDING GLYCOSAMINOGLICANS WITH CONTROLLED VISCOSITY AND USE OF SUCH COMPOSITION IN THE THERAPY OF CHRONIC CYSTITIS
DE102006060953A1 (en) * 2006-12-12 2008-08-07 Farco-Pharma Gmbh Synergistic preparation for treating urinary tract inflammation, e.g. cystitis, contains low molecular hyaluronic acid and another glycosaminoglycan, preferably chondroitin sulfate
ES2405314T3 (en) * 2008-05-13 2013-05-30 Apharm S.R.L. Compositions and oral use of glycosaminoglycans
US9241953B2 (en) 2008-05-13 2016-01-26 Apharm S.R.L. Glycosaminoglycan oral use and compositions
TWI516269B (en) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
TWI383796B (en) * 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
FR2959415B1 (en) * 2010-04-30 2012-07-13 Ayawane DERMATOLOGICAL COMPOSITION BASED ON ARGAN OIL AND HYALURONIC ACID.
FI20115631A0 (en) 2011-06-21 2011-06-21 Turun Yliopisto IMMUNOSTIMULATORY COMPOUNDS AND USES THEREOF
ITMI20130117A1 (en) * 2013-01-25 2014-07-26 Gnosis Spa COMPOSITIONS INCLUDING CONDROITIN SULFATE, PROTEOLITHIC ENZYMES AND COMPOUNDS OF SULFIDRYLATES TO IMPROVE THE BIOAVAILABILITY OF CONDROITIN SULFATE
EP3479830B1 (en) * 2016-04-25 2024-09-11 College of Animal Science & Technology, Qingdao Agriculture University Application of small-molecule hyaluronic acid fragment
CN108721320A (en) * 2017-04-24 2018-11-02 惠觅宙 The application of micromolecule hyaluronic acid segment
CN107303271A (en) * 2016-04-25 2017-10-31 惠觅宙 A kind of parenteral solution containing micromolecule hyaluronic acid and application thereof
JP2023510089A (en) * 2019-12-13 2023-03-13 フォリウムラボ インコーポレーティッド Complexes Comprising Carbohydrate Polymers and Active Ingredients and Methods for Their Preparation

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005517A1 (en) * 1986-03-14 1987-09-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid useful as antimicrobial agents
EP0254845A2 (en) * 1986-06-10 1988-02-03 Lescarden Inc. Immune stimulation with chondroitin sulfate
WO1988001280A1 (en) * 1986-08-21 1988-02-25 Board Of Regents, The University Of Texas System Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness or metastatic profusion
WO1991013624A1 (en) * 1990-03-05 1991-09-19 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Endogenous, suramin-induced, sulfated glycosaminoglycans as anti-cancer agents in humans
EP0509120A1 (en) * 1991-04-18 1992-10-21 LABORATORI BALDACCI Spa Topical use of glycosaminoglycans in the prevention and treatment of diseases affecting the cervical vaginal tract
WO1996006622A1 (en) * 1991-07-03 1996-03-07 Hyal Pharmaceutical Corporation Hyaluronic acid and derivatives for modulation of cellular activity
WO1997040841A1 (en) * 1996-04-29 1997-11-06 Hyal Pharmaceutical Corporation Use of formes f hyaluronic acid (ha) for the treatment of cancer
US5929050A (en) * 1998-02-27 1999-07-27 Petito; George D. Chondroitin sulfate composition and method for wound treatment
WO2000008061A1 (en) * 1998-08-05 2000-02-17 Jasper Ltd. Liability Co. Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005517A1 (en) * 1986-03-14 1987-09-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid useful as antimicrobial agents
EP0254845A2 (en) * 1986-06-10 1988-02-03 Lescarden Inc. Immune stimulation with chondroitin sulfate
WO1988001280A1 (en) * 1986-08-21 1988-02-25 Board Of Regents, The University Of Texas System Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness or metastatic profusion
WO1991013624A1 (en) * 1990-03-05 1991-09-19 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Endogenous, suramin-induced, sulfated glycosaminoglycans as anti-cancer agents in humans
EP0509120A1 (en) * 1991-04-18 1992-10-21 LABORATORI BALDACCI Spa Topical use of glycosaminoglycans in the prevention and treatment of diseases affecting the cervical vaginal tract
WO1996006622A1 (en) * 1991-07-03 1996-03-07 Hyal Pharmaceutical Corporation Hyaluronic acid and derivatives for modulation of cellular activity
WO1997040841A1 (en) * 1996-04-29 1997-11-06 Hyal Pharmaceutical Corporation Use of formes f hyaluronic acid (ha) for the treatment of cancer
US5929050A (en) * 1998-02-27 1999-07-27 Petito; George D. Chondroitin sulfate composition and method for wound treatment
WO2000008061A1 (en) * 1998-08-05 2000-02-17 Jasper Ltd. Liability Co. Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 199341, Derwent World Patents Index; AN 1993-325668, XP002445595 *
See also references of WO0209728A1 *

Also Published As

Publication number Publication date
NZ533078A (en) 2006-11-30
CA2417867A1 (en) 2002-02-27
CA2417867C (en) 2012-09-11
AU2001281368B2 (en) 2005-07-28
AU8136801A (en) 2002-02-13
NZ524076A (en) 2004-07-30
EP1311276A1 (en) 2003-05-21
WO2002009728A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
AU8136801A (en) Methods of preventing or treating diseases and conditions using complex carbohydrates
EP1200086A4 (en) Methods for treating or preventing pain and anxiety
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
EP1267798A4 (en) Treatment of skin damage using polyenylphosphatidylcholine
EP1283702A4 (en) Medical dressing assembly and associated method of using the same
EP1217963A4 (en) Devices and methods for treating tissue
AU1166502A (en) Human ect2 and methods of use
GB9824436D0 (en) Methods of treatment
IL160835A0 (en) Catheter and method of using same
EP1463495A4 (en) Agents and methods for treatment of cancer
AU5754701A (en) Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2mediated disorders
AU2002237667A1 (en) Methods for the treatment and prevention of urinary stone disease
AU2001240046A1 (en) Method of treating skin conditions
IL148202A0 (en) Copolymers and methods of treating prion-related diseases
GB0115707D0 (en) Treatment and prevention of lipodermatosclerosis
GB2360453B (en) Treatment of skin conditions
EP1435970A4 (en) Methods of treating skin with diphosphonate derivatives
AU6970101A (en) Method for treatment and prevention of mastitis
EP1263935A4 (en) Scytonemin and methods of using thereof
AU6746501A (en) Methods for prevention of ulcers and improving physiological performance
GB0008921D0 (en) Method of treatment
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
EP1190089A4 (en) Methods of treatment using lig 72a and variants thereof
EP1303281A4 (en) Methods of treatment
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030211

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20070816

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071115